HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311,521 | +26.2% | 8,155 | +19.1% | 0.01% | +25.0% |
| Q2 2023 | $246,899 | -11.8% | 6,845 | -6.6% | 0.00% | 0.0% |
| Q1 2023 | $279,971 | -38.2% | 7,331 | -7.9% | 0.00% | -42.9% |
| Q4 2022 | $452,981 | -5.4% | 7,961 | -34.3% | 0.01% | -22.2% |
| Q3 2022 | $479,000 | -0.6% | 12,113 | +10.7% | 0.01% | 0.0% |
| Q2 2022 | $482,000 | +17.6% | 10,947 | +6.4% | 0.01% | +28.6% |
| Q1 2022 | $410,000 | -0.7% | 10,292 | +0.2% | 0.01% | 0.0% |
| Q4 2021 | $413,000 | -1.2% | 10,273 | +0.3% | 0.01% | -22.2% |
| Q3 2021 | $418,000 | +8.3% | 10,243 | +20.5% | 0.01% | +12.5% |
| Q2 2021 | $386,000 | +8.7% | 8,503 | -0.1% | 0.01% | 0.0% |
| Q1 2021 | $355,000 | -3.0% | 8,511 | -0.6% | 0.01% | -20.0% |
| Q4 2020 | $366,000 | +36500.0% | 8,561 | +34144.0% | 0.01% | – |
| Q3 2020 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |